Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Capital Employed (2019 - 2025)

Neurogene (NGNE) has disclosed Return on Capital Employed for 4 consecutive years, with 0.33% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Return on Capital Employed fell 4.0% year-over-year to 0.33%, compared with a TTM value of 0.33% through Jun 2025, down 4.0%, and an annual FY2019 reading of 0.66%, changed N/A over the prior year.
  • Return on Capital Employed was 0.33% for Q2 2025 at Neurogene, down from 0.29% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.2% in Q1 2024 and bottomed at 0.41% in Q3 2024.